Metoprolol Succinate Tablet, Extended Release
Product Images NDC 68001-358

6 FDA label images from Bluepoint Laboratories · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Metoprolol Succinate (NDC 68001-358). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Bluepoint Laboratories, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Image-01 (Image 01)

Image-01 (Image 01)
Chemical structure diagram of the active ingredient Metoprolol Succinate, showing its molecular components and arrangement.*
FDA Label Image

Image-02 (65d59c7d 3d7e 4210 Af08 7bb02029294a 00)

Image-02 (65d59c7d 3d7e 4210 Af08 7bb02029294a 00)
A forest plot titled 'Results for Subgroups in MERIT-HF' showing relative risk and 95% confidence intervals comparing Metoprolol Succinate Extended-Release Tablets to Placebo across various subgroups for three outcomes: Total Mortality, Total Mortality or All-Cause Hospitalization, and Total Mortality or Hospitalization for Heart Failure. Subgroups include location (US/non-US), NYHA class, ejection fraction, ischemic etiology, sex, race, previous myocardial infarction, diabetes status, hypertension history, and heart rate categories.*
FDA Label Image

Metoprolol Er Tabs Usp Label 25mg 100s Rev 052018 (Metoprolol Er Tabs Usp Label 25mg 100s Rev 052018)

Metoprolol Er Tabs Usp Label 25mg 100s Rev 052018 (Metoprolol Er Tabs Usp Label 25mg 100s Rev 052018)
Label for Metoprolol Succinate Extended-Release Tablets USP, 25 mg strength, containing 100 tablets. The label includes the NDC 68001-356-00, barcodes, storage instructions, and warnings. It is manufactured by Novast Laboratories Ltd. for BluePoint Laboratories. The label advises referring to the package insert for dosage information.*
FDA Label Image

Metoprolol Er Tabs Usp Label 50mg 100s Rev 052018 (Metoprolol Er Tabs Usp Label 50mg 100s Rev 052018)

Metoprolol Er Tabs Usp Label 50mg 100s Rev 052018 (Metoprolol Er Tabs Usp Label 50mg 100s Rev 052018)
Label for Metoprolol Succinate Extended-Release Tablets, USP 50 mg by BluePoint Laboratories. The label indicates each tablet contains 47.5 mg metoprolol succinate, equivalent to 50 mg metoprolol tartrate. It shows the NDC 68001-357-00, package size of 100 tablets, and storage instructions. Manufactured by Novast Laboratories Ltd. in China for BluePoint Laboratories.*
FDA Label Image

Metoprolol Er Tabs Usp Label 100mg 100s Rev 052018 (Metoprolol Er Tabs Usp Label 100mg 100s Rev 052018)

Metoprolol Er Tabs Usp Label 100mg 100s Rev 052018 (Metoprolol Er Tabs Usp Label 100mg 100s Rev 052018)
Label for Metoprolol Succinate Extended-Release Tablets, USP, 100 mg strength. The label shows this is a prescription medication manufactured by Novast Laboratories Ltd., Nantong, China, for BluePoint Laboratories. The package contains 100 tablets. Storage instructions and warnings about keeping medications out of reach of children are included.*
FDA Label Image

Metoprolol Er Tabs Usp Label 200mg 100s Rev 052018 (Metoprolol Er Tabs Usp Label 200mg 100s Rev 052018)

Metoprolol Er Tabs Usp Label 200mg 100s Rev 052018 (Metoprolol Er Tabs Usp Label 200mg 100s Rev 052018)
Label for Metoprolol Succinate Extended-Release Tablets USP, 200 mg strength, containing 100 tablets. Manufactured by Novast Laboratories Ltd., Nantong, China for BluePoint Laboratories. The label includes the NDC 68001-360-00, dosage instructions reference, a warning to keep out of reach of children, and storage conditions. Barcodes and revision information are also visible.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.